Skip to main content
An official website of the United States government
Email

TARGET Cancers Selected for Study

Below is the list of cancers selected for study by NCI’s Therapeutically Applicable Research to Generate Effective Treatments (TARGET) program. For each cancer type, TARGET researchers have published an overview of the characterizations performed and multiple types of analyses of the data. For some diseases, data collection and analysis occurred in separate phases.

Supplemental and associated data files for these studies can be found on the publication pages at the GDC.

TARGET's Pediatric Cancers Selected for Study

Cancer Type Studied

# Cases Characterized

Publication
Acute Lymphoblastic Leukemia1,802
  1. Nat Gen 2022
  2. Nature 2018 (data)
  3. Nat Gen 2017 (data)
  4. Nat Commun 2015 (data)
  5. N Engl J Med 2014 (data)
  6. Hematology Am Soc Hematol Educ Program 2012 (data)
  7. Blood 2013 (data)
  8. Cancer Cell 2012 (data)
  9. Blood 2011 (data)
  10. Nat Genet 2011
  11. Blood 2010 (data)
  12. Blood 2010 (data)
  13. Blood 2010 (data)
  14. Proc Natl Acad Sci 2009 (data)
  15. N Engl J Med 2009 (data) 
Acute Myeloid Leukemia2,145
  1. Nat Commun 2022
  2. Br J Cancer 2020
  3. Cancer Inform 2019
  4. Leukemia 2019 (data)
  5. Nat Med 2018b
  6. Nat Med 2018a (data)
  7. J Clin Oncol 2017 (data)
  8. Blood 2016 (data)
  9. Cancer Res 2016 (data)

Kidney Tumors

  
     Wilms652
  1. PLoS One 2018
  2. Nat Genet 2017 (data)
  3. Clin Cancer Res 2016 (data)
  4. Nat Commun 2015 (data)
  5. Cancer Cell 2015 (data)
     Clear Cell Sarcoma13
  1. Oncotarget 2015 (data)
     Rhabdoid Tumor69
  1. Cell Rep 2019 (data)
  2. Cancer Cell 2016 (data)
Neuroblastoma1,132
  1. Clin Cancer Res 2018 (data)
  2. Oncogene 2018
  3. Cancer Discov 2018
  4. Nature 2015 (data)
  5. Nat Genet 2015 (data)
  6. Nat Genet 2013 (data)
Osteosarcoma383
  1. Oncotarget 2017
Meta-Analysis Studies 
  1. Nature 2018 (data)
  2. J Clin Oncol 2010
Pan-Cancer Model Systems 
  1. Cell Rep 2019 (data)
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “TARGET Cancers Selected for Study was originally published by the National Cancer Institute.”

Email